CTGF/Hcs24 induces chondrocyte differentiation through a p38mitogen-activated protein kinase p38MAPK, and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase ERK Ge
Trang 1CTGF/Hcs24 induces chondrocyte differentiation through a p38
mitogen-activated protein kinase (p38MAPK), and proliferation
through a p44/42 MAPK/extracellular-signal regulated kinase (ERK)
Gen Yosimichi1,2, Tohru Nakanishi1, Takashi Nishida1,3, Takako Hattori1, Teruko Takano-Yamamoto2and Masaharu Takigawa1,3
1 Department of Biochemistry and Molecular Dentistry, and2Department of Orthodontics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;3Biodental Research Center, Okayama University Dental School, Japan
Connective tissue growth factor/hypertrophic chondrocyte
specific gene product 24 (CTGF/Hcs24) promotes
pro-liferation and differentiation of chondrocytes in culture We
investigated the roles of two major types of mitogen
acti-vated protein kinase (MAPK) in the promotion of
prolif-eration and differentiation by CTGF/Hcs24 Here we report
the effects of the MAPKK/MEK 1/2 inhibitor, PD098059,
and p38 MAPK inhibitor, SB203580, in a human
chondro-sarcoma-derived chondrocytic cell line (HCS-2/8) and
rabbit growth cartilage (RGC) cells treated with CTGF/
Hcs24 In the proliferation phase, CTGF/Hcs24 induced a
< fivefold increase in the phosphorylation of p44/42
MAPK/ERK and a < twofold increase in that of p38
MAPK in an in vivo kinase assay These inhibitors
of MAPKK and MAPK suppressed phosphorylation of
ets-like gene-1 (Elk-1) and nuclear activating transcription
factor-2 (Atf-2) induced by CTGF/Hcs24 in a dose-dependent
manner, respectively Western blot analysis showed that phosphorylation of ERK was induced from 30 to 60 min and phosphorylation of p38 MAPK from 10 to 15 min after the addition of CTGF/Hcs24 in confluence HCS-2/8 cells PD098059 suppressed the DNA synthesis of HCS-2/8 cells and RGC cells, while SB203580 did not On the other hand, the p38 MAPK inhibitor, SB203580, completely inhibited the CTGF/Hcs24-induced synthesis of proteoglycans in HCS-2/8 cells and RGC cells but the MEK1/2 inhibitor, PD098059, did not These results suggest that ERK mediates the CTGF/Hcs24-induced proliferation of chondrocytes, and that p38 MAPK mediates the CTGF/Hcs24-induced differentiation of chondrocytes
Keywords: connective tissue growth factor; hypertrophic chondrocyte specific gene product (CTGF/Hcs24); MAPK; chondrocyte; MAPK inhibitor; signal transduction
Connective tissue growth factor/hypertrophic chondrocyte
specific gene product 24 (CTGF/Hcs24) is a cysteine-rich,
heparin-binding protein Its gene and two other genes, cef10/
cyr61 and nov, belong to the CCN gene family [1 – 5]
Recently, new members of this family, wisp2/rcop-1 [6],
wisp3/elm1 [7,8], and ctgf-L [9], were isolated, but the
functions of these genes are unknown We cloned a mRNA
preferentially expressed in chondrocytes from a human
chondrosarcoma-derived chondrocytic cell line, HCS-2/8
[10,11] by differential display-PCR [12] The gene product
was identical to CTGF CTGF/Hcs24 is strongly expressed
on hypertrophic chondrocytes in growth plate of cartilage [12], and promotes proliferation and differentiation of chon-drocytes in culture [13] In addition, CTGF/Hcs24 promotes both proliferation and differentiation of osteoblasts [14] Although a CTGF/Hcs24-specific receptor [15] is yet to be cloned, a CTGF/Hcs24-receptor complex with an apparent molecular mass of 280 kDa was tyrosine-phophorylated
in HCS-2/8 cells (data not shown) CTGF/Hcs24 has also multiple effects on fibroblasts [16], endothelial cells [17,18], and tumor cells [19] CTGF/Hcs24 is highly expressed in the process of wound healing, and mediates fibrotic disorder [4,17,18] CTGF/Hcs24 and Cyr61 are potential angio-genetic factors [3 – 5,18], and directly bind to integrin aVb3 and aIIbb3 on fibloblasts [20,21] CTGF/Hcs24 and Cyr61 induce adhesion of human fibloblasts mediated by integrin
a6b1 and cell surface heparan sulfate proteoglycans, and activate intracellular signaling molecules including focal adhesion kinase (FAK), paxillin, and Rac, and sustained phosphorylation of ERK [22] Recently, the transcriptional mechanism of CTGF/Hcs24 was revealed [23], and it was also reported that intracellular CTGF/Hcs24 may act as an antimitotic agent [24] But the mechanisms of the multiple functions of CTGF/Hcs24 described above are not well understood
MAPK pathways are essential mitogenic pathways in many cell lines and responsible for various growth factors MAPK is activated by a wide variety of growth factors such
Correspondence to M Takigawa, Department of Biochemistry and
Molecular Dentistry, Graduate school of Medicine and Dentistry,
Okayama University Dental School, 2-5-1 Shikata-cho Okayama
700-8525, Japan Fax: 1 81 86 2356649, Tel.: 1 81 86 235 6645,
E-mail: takigawa@md.okayama-u.ac.jp
(Received 21 May 2001, revised 1 August 2001, accepted 21 September
2001)
Abbreviations: CTGF/Hcs24, connective tissue growth factor/
hypertrohic chondrocyte specific gene product 24; Elk-1, ets-like
gene-1; Atf-2, nuclear activating transcription factor-2; DMEM,
Dulbecco’s modified Eagle’s medium; aMEM, alpha minimal essential
medium; MAPK, mitogen-activated protein kinase; ERK,
extracellular-signal regulated kinase; HCS-2/8, human chondrosarcoma-derived
chondrocytic cell line clone 2/8; RGC, rabbit growth cartilage cells;
GDF-5, growth differentiation factor-5; PTH, parathyroid hormone;
EGF, epidermal growth factor.
Trang 2as epidermal growth factor (EGF) [25], nerve growth factor
(NGF) [26], fibroblast growth factor (FGF) [27], and
trans-forming growth factor (TGF)-b [28,29], and directs
phos-phorylation of transcription factors, such as ets-like gene-1
(Elk-1) [30], nuclear activating transcription factor-2 (Atf-2)
[31], and c-Jun [32], and other kinases MAPK cascades are
composed of many kinds of kinases and are intricately
regulated However, downstream of these pathways can
simply be classified into three major groups mediated by the
following kinases; p44/42 MAPK/ERK, p38 MAPK, and
c-jun N-terminal kinase (JNK) It is reported that Elk-1 and
Atf-2 are phosphorylated by ERK and p38 MAPK,
respec-tively [30,33,34]
In this study, we investigated the signal transducible
pathways of CTGF/Hcs24 responsible for its multiple
roles in the proliferation and differentiation of chondrocytes,
and analyzed the relationship between the MAPK pathways
and the proliferation and differentiation of CTGF/Hcs24,
using two MAPK inhibitors, the MEK1/2-specific inhibitor,
PD098059 [35,36], and the p38 MAPK inhibitor, SB203580
[37,38]
M A T E R I A L S A N D M E T H O D S
Cell culture and materials
A human chodrosarcoma-derived chondrocytic cell line,
HCS-2/8, was inoculated at a density of 2 104per cm2in
96-well plates, 24-well plates, and six-well plates
(Sumitomo Bakelite Co Ltd, Tokyo, Japan) and cultured
in Dulbecco’s modified Eagle’s medium (DMEM; Nissui
Pharmaceutical Co Ltd, Tokyo, Japan) containing 10% fetal
bovine serum (Upsdate Biotechnology, Inc., Lake Placid,
NY, USA), and 50 ng:mL21of human recombinant CTGF/
Hcs24 (rCTGF/Hcs24) For the inhibitor assay, 50 mM of
MEK1/2 inhibitor (PD098059, Calbiochem, San Diego,
CA, USA), or 10 mM of p38 MAPK inhibitor (SB203580,
Calbiochem) was added to the culture after 24 h of serum
depletion, and cells were harvested after 12 h of incubation
Rabbit growth cartirage (RGCs) cells were isolated from
growth cartilage of ribs of young rabbits as described
previously [13,39,40] The isolated cells were inoculated at
a density of 1 104per cm2in 96-well plates, 24-well plates,
and six-well plates (Sumitomo Bakelite Co Ltd), and
cultured in aMEM (alpha minimal essential medium, ICN
Biomedicals, Inc., Costa Mesa, CA, USA) containing 10%
fetal bovine serum
In vivo MAP kinase luciferase assay
ERK phosphorylation was quantified using an MAPK
in vivo kinase assay kit and p38K in vivo kinase assay kit
(Clontech) according to the manufacturer’s protocol This
system is designed to detect endogeneous ERK and p38
MAPK activity in vivo A pTet-Elk or pTet-Atf vector
expresses a fusion protein with the functional domain of Elk
or Atf and Tet repressor (TetR) domain The reporter vector,
pTRE-Luc, contains a tet-responsive element (TRE)
upstream of the luciferase gene Phosphorylation of Elk by
ERK, or Atf by p38 MAPK causes homodimeriization of
these proteins that induces DNA binding through the TRE
element, and results in the activation of the reporter gene
For this experiment, 3 105 HCS-2/8 cells in a 35-mm
tissue culture dish were transiently cotransfected with 1 mg
of pTRE-luc, 1 mg of pTet-Elk or pTet-Atf by FuGENETM6 (Roche, Indianapolis, IN, USA) An internal control plasmid, 0.5 mg of pRL-TK, was also cotransfected for monitoring transfection efficiency At 24 h post-transfection, the cells were incubated with various concentrations of PD098059 or SB203580 for 1 h, and cells were cultured with or without
50 ng:mL21 of rCTGF/Hcs24 for 24 h The cell lysates were prepared and assayed for luciferase activity using the Dual-LuciferaseTM Reporter Assay System (Promega) according to the manufacturer’s instructions Light emission was measured for 12 – 24 s with a luminometer (TD-20/20: Tuner Design, Sunnyvale, CA, USA)
Western blotting Total cellular protein was prepared by lysing cells in lysis buffer [20 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM Na (VO4), 5% glycerol,
40 mM ammonium molybdate, and 1 mM phenylmethane-ulfonyl flyoride] Then, 4 mg of the protein was separated by
4 – 20% gradient SDS/PAGE and electrophoretically trans-ferred to poly(vinylidene difluoride) filters (Bio-Rad) The filters were blocked with 5% nonfat drymilk in Tris-buffered saline (pH 7.5) containing 0.1% Tween 20 for 30 min at room temparature and then incubated with anti-ERK Ig, anti-(active-ERK) Ig, anti-(p38 MAP) Ig or anti-(active-p38 MAPK) Ig (New England BioLaboratories, Bevely, MA, USA, Calbiochemistry, San Diego, CA, USA and Santa Cruz Biochemistry, Santa Cruz, CA, respectively) for 24 h
at 4 8C The filters were then incubated with the secondary antibodies [horseradish peroxidase-conjugated anti-(rabbit IgG) Ig (DAKO, Trappes, France), and alkaline phospha-tase-conjugated anti-(rabbit IgM) Ig (Cappel, Durham, NC, USA)], and the signal was detected by enhanced chemiluminescence (Amersham Pharmacia), or colored with nitro blue tetrazolium and 5-bromo-4-chloroindolyl phosphate (BCIP)
DNA synthesis For measurement of DNA synthesis, HCS-2/8 cells were inoculated at a density of 2 104 per well in 96-well multiplates with 100 mL of DMEM containing 10% fetal bovine serum When they reached subconfluence, the medium was changed to fetal-bovine-serum-free DMEM and preincubated for 24 h In the case of RGC cells, the cells were inoculated at a density of 1 104per well in 100 mL of aMEM containing 10% fetal bovine serum When they reached confluence, the medium was changed to fetal-bovine-serum-free aMEM, and preincubated for 48 h MAPK inhibitors (50 mM of PD098059, 10 mM of SB203580) were added to the culture 1 h before the addition of 50 ng:mol21of rCTGF/Hcs24 After 22 h, [3H]thymidine (9925 Tbq:nmol21; Amersham Pharmacia Biotech), dissolved in DMEM was added to the cultures at a final concentration of
740 KBq:mL21, and cells were incubated for another 4 h After labeling, the cell layers were washed three times with NaCl/Pi and treated successively with 5% trichloroacetic acid and ethanolethyl ether (3 : 1, v/v) Radioactivity in the residual materials was measured using a Micro b-PLUS (Pharmacia Biotech), as described previously [13,15]
Trang 3Proteoglycan synthesis
Proteoglycan synthesis was assayed as described previously
[10,15] with slight modification HCS-2/8 cells were grown
to confluence in 24-well microplates in DMEM containing
10% fetal bovine serum They were then preincubated in
DMEM without fetal bovine serum for 24 h and incubated
in the same medium with rCTGF/Hcs24 (50 ng:mL21) for
5 h Then, [35S]sulfate (37 MBq:mL21) dissolved in NaCl/
Pi was added to the cultures to a final concentration of
370 kBq:mL21, and incubation was continued for another
17 h After labeling, the cultures were digested with
1 mg:mL21 actinase E (Kaken Pharmaceuticals, Tokyo,
Japan), and the radioactivity of the material precipitated
with cetylpyridium chloride was measured in a scintillation
counter
Statistical analysis
Unless otherwise specified, all experiments were repeated at
least twice, with similar results One-way analysis of variance
(ANOVA) was used for statistical evaluation Statistical
analysis was performed by the Dunnett test if necessary
Data are expressed as the mean ^ SD and P , 0.05 was
considered significant
R E S U L T S
In vivo MAP kinase and p38 MAPK luciferase assay
HCS-2/8 cells were transiently cotransfected with an Elk or
Atf expression vector, pTet-Elk or pTet-Atf, together with a
pTRE-luc plasmid that contains a luciferase reporter gene
Transfected cells were subsequently treated with various
concentrations of rCTGF/Hcs24 The luciferase activity in
this experiment reflects endogeneous ERK and p38 MAPK
phosphorylation activity The luciferase activity increased
on incubation with rCTGF/Hcs24 in a dose-dependent
manner (Fig 1) A high dose of CTGF/Hcs24 (50 ng:mL21)
caused a fivefold increase in the MAPK luciferase activity
(Fig 1A), but the same concentration of rCTGF/Hcs24
caused only a twofold increase in the p38 MAPK luciferase
activity (Fig 1B) To check the phosphorylation of Elk by
ERK and Atf by p38 MAPK through the activation of
MEK1/2 and p38 MAPK, we used PD098059, a MEK1/
2-specific inhibitor and SB203580, a p38 MAPK inhibitor in
the same assay (Fig 2) Phosphorylation of Elk (Fig 2A) or
Atf (Fig 2B) was suppressed by each inhibitor
dose-dependently
Effects of rCTGF/Hcs24 on phosphorylation of ERK and
p38 MAP kinase in HCS-2/8 cells
We analyzed the effects of rCTGF/Hcs24 on the
phosphory-lation of two major types of MAP kinases, ERK and p38
MAP kinase, by Western blotting in HCS-2/8 cells (Fig 3)
We determined that CTGF/Hcs24 stimulated the
phosphory-lation of the kinases with different time kinetics
Interest-ingly, CTGF/Hcs24 induced a slow phosphorylation of ERK
from 10 min after the treatment with a maximal effect
observed at 30 min (Fig 3A) This was different from other
growth factors that promote proliferation On the other hand,
rCTGF/Hcs24 induced a rapid phosphorylation of p38
MAPK from 10 to 30 min after the addition (Fig 3B) The
MEK1/2-specific inhibitor, PD098059, and p38 MAPK-specific inhibitor, SB203580, inhibited the phosphorylation
of each MAP kinase induced by rCTGF/Hcs24 (Fig 4A,B) But neither inhibitor had an effect on the different phosphorylation of MAP kinase
Effects of MAP kinase inhibitors on DNA synthesis in HCS-2/8 and RGC cells
To investigate the signal pathways for proliferation of chondrocytes induced by CTGF/Hcs24, we performed DNA
Fig 1 In vivo MAPK and p38 MAPK luciferase activity induced
by CTGF/Hcs24 in the sparse phase of HCS-2/8 cells Elk-1 (A) and Atf-2 (B) phosphorylation induced by CTGF/Hcs24 through endo-geneous ERK and p38 MAPK, respectively HCS-2/8 cells were cotransfected with the fusion transactivater plasmid, pTet-Elk (A) and pTet-Atf (B) and the reporter plasmid, pTRE-luc, as described in Materials and methods At 24 h after transfection, the cells were serum-deprived for 24 h, and incubated with the indicated concentrations of CTGF/Hcs24 for 24 h Extracts prepared thereafter were assayed for luciferase activity using the Dual-Luciferase TM Reporter Assay System.
In these system, firefly luciferase is used as an expression reporter of TRE (pTRE-Luc), and TK drived renilla luciferase is usd as a transfection control (pRL-TK) These plasmids were cotransfected to HCS-2/8 cells F/R ratio indicates the ratio of luciferase activity of firefly (F) and renilla (R) Points and bars are the mean ^ SD for duplicate cultures *, P , 0.05; **, P , 0.01 (significantly different from the control culture).
Trang 4synthesis analysis by estimating incorporation of [3
H]thymi-dine in HCS-2/8 (Fig 5A) and RGC cells (Fig 5B) rCTGF/
Hcs24 at a concentration of 50 ng:mL21 induced about a
1.5-fold increase in DNA synthesis both in HCS-2/8 and in
RGC cells (Fig 5A,B, bar 2) compared to the control
culture (Fig 5A,B, bar 1) In HCS-2/8 cells, treatment with
50 mMof the MEK1/2 inhibitor, PD098059, suppressed the
degree of DNA synthesis in the control culture by about half, either with (Fig 5A, bar 3) or without rCTGF/Hcs24 (Fig 5A, bar 5) On the other hand, 10 mM of the p38 MAPK inhibitor, SB203580 suppressed DNA synthesis in HCS-2/8 cells induced by CTGF/Hcs24, but had no effect
in the control culture (Fig 5A, bars 1 and 6) without rCTGF/ Hcs24 (Fig 5A, bar 6) In RGC cells (Fig 5B), rCTGF/ Hcs24 induced about a 1.5-fold increase in the synthesis of DNA similar (Fig 5B, bar 2) to the control (Fig 5B, bar 1) PD098059 inhibited the effect of CTGF/Hcs24 (Fig 5B, bar 3), but had no effect on the basal level of DNA synthesis in RGC cells (Fig 5B, bar 5) SB203580 treatment did not suppress the synthesis of DNA in RGC cells with or without rCTGF/Hcs24 (Fig 5B, bar 6) SB203580 did not decrease the synthesis further in PD098059-treated cells (Fig 5B, bar7)
Effects of MAP kinase inhibitors on proteoglycan synthesis of HCS-2/8 and RGC cells
Previously we reported that CTGF/Hcs24 dose-dependently enhanced proteoglycan synthesis in HCS-2/8 cells and RGC cells [13] To investigate the intracellular pathways for the stimulatory action of CTGF/Hcs24 on chondrocyte differ-entiation, we examined proteoglycan synthesis in HCS-2/8 cells (Fig 6A) and RGC cells (Fig 6B) in the presence of MAP kinase inhibitors Addition of 50 ng:mL21of rCTGF/ Hcs24 promoted the synthesis of proteoglycans by about twofold in both HCS-2/8 cells (Fig 6A, bar 2) and RGC cells (Fig 6B, bar 2) relative to control cultures (Fig 6A,B, bar 1) Treatment with 50 mM of the MEK1/2 inhibitor, PD098059 did not inhibit the stimulatory effect of rCTGF/ Hcs24 (Fig 6A,B, bar 3), but 10 mM of the p38 MAPK inhibitor, SB203580 suppressed the stimulatory effects of rCTGF/Hcs24 in HCS-2/8 cells (A bar 4) and RGC cells (B bar 4) The inhibitors had no effect on the basal level of
Fig 3 Effects of CTGF/Hcs24 on phosphorylation of ERK (A) and
p38 MAPK (B) in confluent HCS-2/8 cells Western blot analysis
revealed that stimulation with CTGF/Hcs24 increased the
phosphoryl-ation of ERK from 10 min to 30 min (A) Stimulphosphoryl-ation with CTGF/
Hcs24 also increased the phosphorylation of p38 MAPK peaked from
10 to 30 min (B).
Fig 2 Effects of MAP kinase inhibitors (PD098059, SB203580) on
phosphorylation of Elk-1 and Atf-2 induced by CTGF/Hcs24
HCS-2/8 cells were cultured under the same conditions as for Fig 1 CTGF/
Hcs24 (50 ng:mL21) was added after 1 h pretreatment with various
concentrations of MAP kinase inhibitors (PD098059, A; SB203580, B).
CTGF/Hcs24-induced phosphorylation of Elk-1 (A) and Atf-2 (B)
through endogeneous ERK was suppressed by PD098059 (A) and
SB203580 (B), respectively, dose-dependently F/R ratio indicates the
ratio of luciferase activity of firefly (F) and renilla (R) Points and bars
are the mean ^ SD for duplicate cultures *, P , 0.05; **, P , 0.01
(significantly different from the control culture).
Fig 4 Effects of MAPK inhibitors (50 m M PD098059 and 10 m M
SB203580) on phosphorylation of ERK (A) and p38 MAPK (B) determined by Western blotting (A) Phosphorylation of ERK was enhanced by CTGF/Hcs24 at 30 min Treatment with 50 m M PD098059 decreased the amount of phosphorylated ERK but treatment with
10 m M SB203580 had no effect (B) Phosphorylated p38 MAPK was increased at 15 min and 30 min, and the increase was suppressed by SB203580 PD098059 treatment had no effect on the amount of phosphorylated p38 MAPK.
Trang 5proteoglycan synthesis in HCS-2/8 cells (Fig 6A, bars 5
and 6) and RGC cells (Fig 6B, bars 5 and 6)
D I S C U S S I O N
In this study, we first investigated the phosphorylation of
two major types of MAP kinase induced by CTGF/Hcs24
The MAPK cascade is known to be activated by receptor
tyrosine kinase activity induced by growth factors, such as EGF [35], FGF [27], and parathyroid hormone (PTH) [41] and serine threonine kinase activity by TGF-b [28,29] and growth differentiation factor-5 (GDF-5) [42] in chondro-cytes We previously reported that a 280-kDa CTGF/ Hcs24-receptor complex was present in HCS-2/8 cells [14], and a human osteosarcoma cell line, Saos-2 [15], and this receptor complex was thyrosine-phosphorylated by CTGF/ Hcs24 (data not shown) It was also reported that Nov, a member of the CCN family, induced thyrosine-phosphoryl-ation of a 221-kDa protein in fibloblasts [43] These
Fig 5 Effects of MAP kinase inhibitors on DNA synthesis in
HCS-2/8 (A) and RGC cells (B) For the evaluation of DNA synthesis,
HCS-2/8 cells were inoculated at a density of 2 10 4 per well into
96-well multiplates and cultured in 100 mL of DMEM containing 10%
fetal bovine serum, while RGC cells were inoculated at a density of
1 10 4 per well into 96-well multiplates and cultured in 100 mL of
aMEM containing 10% fetal bovine serum When they reached
subconfluence, HCS-2/8 cells were incubated in 100 mL of serum-free
DMEM for 24 h, and RGC cells were incubated in 100 mL of
serum-free aMEM for 24 h, and then 50 ng:mL21of CTGF/Hcs24 was added
to the cultures Next, 50 m M PD098059 and 10 m M SB203580 were
added 1 h before the addition of rCTGF/Hcs24 Dimethylsulfoxide was
added to the control culture DNA synthesis was measured 22 h later as
described in Materials and methods (A) control (bar 1), 50 ng:mL21of
CTGF/Hcs24 (bar 2), 50 m M PD098059 with 50 ng:mL 21 of rCTGF/
Hcs24 (bar 3), 10 m M SB203580 with 50 ng:mL21of CTGF/Hcs24 (bar
4), 50 m M PD098059 (bar 5), 10 m M SB203580 (bar 6), both of the
inhibitors with 50 ng:mL21of rCTGF/Hcs24 (bar 7) Columns and bars
are mean ^ SD for triplicate cultures **, P , 0.01, significantly
different from the control cultures *, P , 0.05, significantly different
from the CTGF/Hcs24 containing cultures.
Fig 6 Effects of MAP kinase inhibitors on proteoglycan synthesis
in HCS-2/8 (A) and RGC cells (B) For estimation of proteoglycan synthesis, confluent cultures of HCS-2/8 cells (A) and RGC cells (B) were preincubated in serum-free DMEM for 24 h and then incubated in the same medium with or without 50 ng:mL21of rCTGF/ Hcs24 Next, 50 m M PD098059 and 10 m M SB203580 was added
1 h before the addition of rCTGF/Hcs24 Dimethylsulfoxide was added
to the control culture and then [ 35 S]sulfate (37 Mbq:mL 21 ) dissolved
in NaCl/P i was added to the cultures (370 kBq:mL21 final concentration), and incubation was continued for another 17 h Proteoglycan synthesis was measured as described in Materials and methods Control (bar 1), 50 ng:mL21of rCTGF/Hcs24 (bar 2),
50 m M PD098059 with 50 ng:mL21of rCTGF/Hcs24 (bar 3), 10 m M
SB203580 with 50 ng:mL 21 of rCTGF/Hcs24 (bar 4), 50 m M
PD098059 (bar 5), 10 m M SB203580 (bar 6), both of the inhibitors with 50 ng:mL21 of rCTGF/Hcs24 (bar 7) Columns and bars are mean ^ SD for duplicate cultures **, P , 0.01, significantly different from the control cultures *, P , 0.05, significantly different from the CTGF/Hcs24-added cultures.
Trang 6observations indicate a possible relation between CTGF/
Hcs24-signal transduction and MAPK cascades The present
study demonstrated that CTGF/Hcs24 potentiated
phosphory-lation of Elk-1, downsream of ERK [30], and Atf-2,
downstream of p38 MAPK [31] in a dose-dependent manner
in HCS-2/8 cells (Fig 1) Both ERK1 and ERK2 have been
shown to be activated by their upstream activaters, MEK1 and
MEK2 A recently developed MEK1/2 inhibitor, PD098059,
has been reported to bind to MEK1/2 and inhibit MEK1/2
phosphorylation activated by either c-Raf or MEKK [35,36]
PD098059 efficiently and specifically suppresses the
activation of ERK in response to various growth factors
[25,26,28,44] The inhibitory effect of PD098059 on MEK2
is less potent than that on MEK1 (IC50values of PD098059
for MEK1 and MEK2 are 4 and 50 mM, respectively) [35]
On the other hand, p38 MAPK is known to be a stress signal
transducer, and phosphorylation of p38 MAPK in
chondro-cytes by EGF [25], PTH [41], and GDF-5 [42] regulates
differentiation of chondrocytes p38 MAPK is
phosphory-lated by MKK3, and MKK6 [45], and Atf-2 is one of the
transcription factors downstream of p38 MAPK [31] A
specific p38 MAPK inhibitor, SB203580 [38], suppresses two
isoforms of p38 MAPK, p38a, and b2, but not p38g [37,46]
In this study, the MEK1/2 inhibitor, PD098059,
dose-dependently suppressed phosphorylation of ERK, and Elk-1
downstream of ERK in the growth phase of HCS-2/8 cells
treated with CTGF/Hcs24 (Fig 2) Similarly, the p38
MAPK inhibitor, SB203580, suppressed phosphorylation of
p38 MAPK, and Atf-2 downstream of p38 MAPK (Fig 2)
Western blot analysis revealed that CTGF/Hcs24 increased
phosphorylation of ERK and p38 MAPK in confluent
HCS-2/8 cells (Fig 3) PD098059 suppressed the
phosphoryl-ation of ERK, but had no effect on the phosphorylphosphoryl-ation of
p38 MAPK In the same way, SB203580 suppressed
phosphorylation of p38 MAPK but not ERK (Fig 4) These
results indicate that both MAPK pathways contributed
selectively to the effects of CTGF/Hcs24
Next, we showed the effects of MAP kinase inhibitors in
both HCS-2/8 cells and RGC cells induced by CTGF/Hcs24
Previously, we reported that CTGF/Hcs24 induced DNA
synthesis, and proteoglycan synthesis in HCS-2/8 cells and
RGC cells [13] We investigated the effects of MAP kinase
inhibitors on pathways of proliferation by analyzing DNA
synthesis, and pathways of differentiation by analyzing
proteoglycan synthesis, in HCS-2/8 and RGC cells In the
case of HCS-2/8 cells, the MEK1/2 inhibitor, PD098059,
suppressed the synthesis of DNA under all conditions, and
the p38 MAPK inhibitor, SB203580, suppressed the
syn-thesis induced by CTGF/Hcs24 to the control level (Fig 5A,
bar 4), but had no effect on the basal level (Fig 5A, bar 6)
As HCS-2/8 cells were tumor cells, their basal levels of
DNA synthesis were high, and proliferation was not under
normal control Therefore we analyzed normal chondrocytic
response in RGC cells, PD098059 suppressed DNA
syn-thesis induced by CTGF/Hcs24 to the control level (Fig 5B,
bar 3) and had no effect on the basal level SB203580 did not
suppress DNA synthesis induced by CTGF/Hcs24, and had
no effect in the absence of CTGF/Hcs24 (Fig 5B, bars 3 and
5) These findings suggest that the ERK pathway has an
important role in chondrocyte proliferation induced by
CTGF/Hcs24
Next, we analyzed proteoglycan synthesis to investigate
the effects of MAP kinase inhibitors on the differentiation of
chondrocytes induced by CTGF/Hcs24 We previously reported that CTGF/Hcs24 induced synthesis of proteo-glycans in HCS-2/8 cells and RGC cells [13] In the present study, as shown in Fig 6, PD098059 had no effect on proteoglycan synthesis in the presence or absence of CTGF/ Hcs24 (Fig 6A,B, bars 3 and 5) On the other hand, SB203580 inhibited the increase in proteoglycan synthesis evoked by CTGF/Hcs24 in HCS-2/8 and RGC cells (Fig 6A,B bar 4) These findings suggest that the p38 MAPK pathway is the most important signalling pathway in the differentiation of chondrocytes The ERK pathway does not seem to be involved in the differentiation of chondrocytes especially when induced by CTGF/Hcs24 Concerning crosstalk between ERK and p38 MAPK, it is reported that GDF-5 phosporylated p38 MAPK and ERK, and p38 MAPK inhibitor inhibited, but MEK1/2 inhibitor enhanced, the chondrogenic response induced by GDF-5 in ATDC5 cells [42] EGF inhibited the chondrogenic differen-tiation of mesenchymal cells, and activated ERK but inhibited p38 MAPK [25] Related to the effect of CTGF/ Hcs24 on chondrocytes, luciferase assay revealed phosphory-lation of Elk-1 was inhibited by the MEK inhibitor but slightly enhanced by treatment with the p38 MAPK inhibitor (data not shown) and phosphorylation of Atf-2 was inhibited
by the p38 MAPK inhibitor and also inhibited slightly by the MEK inhibitor (data not shown) These results suggest that ERK activates both Elk-1 and Atf-2 (Fig 7), and has a dominant effect in the growth phase of cells Furthermore, DNA synthesis indicated that both the ERK and p38 MAPK pathways are involved in the proliferation of chondrocytes induced by CTGF/Hcs24 in tumor cells Also Western blotting shows that SB203580 treatment increased phos-phorylation of ERK (Fig 4, at 0 min), but the effect was not related to synthesis of DNA or proteoglycan (Figs 5 and 6, bars 5 and 6) These results suggest that inhibition of one pathway induces activation of another
In summary, the present results emphasized the functional importance of two MAP kinase cascades, the ERK and p38 MAPK pathways, in the promotion of the chondrogenesis
Fig 7 Possible scheme of MAPK signaling cascades in CTGF/ Hcs24-induced chondrogenesis E, extracellular; M, cell membrane;
C, cytoplasm; N, nucleus.
Trang 7mediated by CTGF/Hcs24 in HCS-2/8 and RGC cells The
ERK pathway plays an important role in the proliferation
of chondrocytes, while the p38 MAPK pathway plays a role
in the differentiation of chondrocytes induced by CTGF/
Hcs24 Our findings suggest that two MAP kinase cascades
mediate various important roles of CTGF/Hcs24 in the
proliferation and differentiation of chondrocytes during
endochondoral ossification
A C K N O W L E D G E M E N T S
This work was supported in part by Grants-in-Aid for Scientific
Research from the Ministry of Education, Science,Sports and Culture of
Japan (to T.N., T.N., and M.T.), and grants from the Foundation for
Growth Science in Japan (to M.T.), the Sumitomo Foundation (to M.T.)
and the Research for the Future Programme of The Japan Society for the
Promotion of Science (JSPS) (Project: Biological Tissue Engineering,
JSPS-RFTF98100201) We thank Drs Satoshi Kubota, Takanori Eguchi,
and Seiji Kondo for useful discussions, Drs Kumiko Nawachi and
Norifumi Moritani for technical assistance, Dr Daisuke Ekuni for
performing the Dunnett test, and Miss Yuki Nonami for secretarial
assistance.
R E F E R E N C E S
1 Bradham, D.M., Igarashi, A., Potter, R.L & Grotendorst, G.R.
(1991) Connective tissue growth factor: a cysteine-rich mitogen
secreted by human vascular endothelial cells is related to the
SRC-induced immediate early gene product CEF-10 J Cell Biol 114,
1285 – 1294.
2 Bork, P (1993) The architecture of a new family of growth
regulators related to connective tissue growth factor FEBS Lett.
327, 125 – 130.
3 Lau, L.F & Lam, S.C (1999) The CCN family of angiogenic
regulators: the integrin connection Exp Cell Res 248, 44 – 57.
4 Brigstock, D.R (1999) The connective tissue growth factor/
cysteine-rich 61/nephroblastoma overexpressed (CCN) family.
Endocr Rev 20, 189 – 206.
5 Takigawa, M (2000) Physiological roles of connective tissue
growth factor (CTGF/Hcs24): promotion of endochondral
ossifica-tion, angiogenesis and tissue remodeling In Tissue Engineering for
Therapeutic Use 4 (Ikada, Y & Shimizu, Y., eds) pp 1 – 13.
Elsevier, Amsterdam, the Netherlands.
6 Zhang, R., Averboukh, L., Zhu, W., Zhang, H., Jo, H., Dempsey,
P.J., Coffey, R.J., Pardee, A.B & Liang, P (1998) Identification of
rCop-1, a new member of the CCN protein family, as a negative
regulator for cell transformation Mol Cell Biol 18, 6131 – 6141.
7 Hashimoto, Y., Shindo-Okada, N., Tani, M., Nagamachi, Y.,
Takeuchi, K., Shiroishi, T., Toma, H & Yokota, J (1998)
Expression of the Elm1 gene, a novel gene of the CCN (connective
tissue growth factor, Cyr61/Cef10, and neuroblastoma
over-expressed gene) family, suppresses in vivo tumor growth and
metastasis of K-1735 murine melanoma cells J Exp Med 187,
289 – 296.
8 Hurvitz, J.R., Suwairi, W.M., Van Hul, W., El-Shanti, H.,
Superti-Furga, A., Roudier, J., Holderbaum, D., Pauli, R.M., Herd, J.K.,
Van Hul, E.V., et al (1999) Mutations in the CCN gene family
member WISP3 cause progressive pseudorheumatoid dysplasia.
Nat Genet 23, 94 – 98.
9 Kumar, S., Hand, A.T., Connor, J.R., Dodds, R.A., Ryan, P.J., Trill,
J.J., Fisher, S.M., Nuttall, M.E., Lipshutz, D.B., Zou, C., et al.
(1999) Identification and cloning of a connective tissue growth
factor-like cDNA from human osteoblasts encoding a novel
regulator of osteoblast functions J Biol Chem 274,
17123– 17131.
10 Takigawa, M., Tajima, K., Pan, H.O., Enomoto, M., Kinoshita, A.,
Suzuki, F., Takano, Y & Mori, Y (1989) Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes Cancer Res 49, 3996 – 4002.
11 Takigawa, M., Pan, H.O., Kinoshita, A., Tajima, K & Takano, Y (1991) Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan- rich cartilage-like nodules and to respond to insulin in vitro Int J Cancer 48, 717 – 725.
12 Nakanishi, T., Kimura, Y., Tamura, T., Ichikawa, H., Yamaai, Y., Sugimoto, T & Takigawa, M (1997) Cloning of a mRNA prefer-entially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF ) mRNA Biochem Biophys Res Commun 234, 206 – 210.
13 Nakanishi, T., Nishida, T., Shimo, T., Kobayashi, K., Kubo, T., Tamatani, T., Tezuka, K & Takigawa, M (2000) Effects of CTGF/ Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture Endocrinology 141, 264 – 273.
14 Nishida, T., Nakanishi, T., Shimo, T., Asano, M., Hattori, T., Tamatani, T., Tezuka, K & Takigawa, M (1998) Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8) Biochem Biophys Res Commun 247, 905 – 909.
15 Nishida, T., Nakanishi, T., Asano, M., Shimo, T & Takigawa, M (2000) Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro J Cell Physiol 184, 197 – 206.
16 Igarashi, A., Okochi, H., Bradham, D.M & Grotendorst, G.R (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair Mol Biol Cell 4, 637 – 645.
17 Shimo, T., Nakanishi, T., Kimura, Y., Nishida, T., Ishizeki, K., Matsumura, T & Takigawa, M (1998) Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells J Biochem 124, 130 – 140.
18 Shimo, T., Nakanishi, T., Nishida, T., Asano, M., Kanyama, M., Kuboki, T., Tamatani, T., Tezuka, K., Takemura, M., Matsumura, T.
& Takigawa, M (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo J Biochem.
126, 137 – 145.
19 Hishikawa, K., Oemar, B.S., Tanner, F.C., Nakaki, T., Luscher, T.F.
& Fujii, T (1999) Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7 J Biol Chem.
274, 37461 – 37466.
20 Babic, A.M., Chen, C.C & Lau, L.F (1999) Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo Mol Cell Biol 19,
2958 – 2966.
21 Jedsadayanmata, A., Chen, C.C., Kireeva, M.L., Lau, L.F & Lam, S.C (1999) Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha (IIb) beta (3) J Biol Chem 274, 24321– 24327.
22 Chen, C.C., Chen, N & Lau, L.F (2000) The angiogenic factors Cyr61 and CTGF induce adhesive signaling in primary human skin fibroblasts J Biol Chem 18, 18.
23 Kubota, S., Kondo, S., Eguchi, T., Hattori, T., Nakanishi, T., Pomerantz, R.J & Takigawa, M (2000) Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/ hcs24 ) gene: similarities to retroviral RNA – protein interactions Oncogene 19, 4773 – 4786.
24 Kubota, S., Hattori, T., Shimo, T., Nakanishi, T & Takigawa, T.
Trang 8(2000) Novel intracellular effects of human connective tissue
growth factor expressed in COS-7 cells FEBS Lett 474, 58 – 62.
25 Yoon, Y.M., Oh, C.D., Kim, D.Y., Lee, Y.S., Park, J.W., Huh, T.L.,
Kang, S.S & Chun, J.S (2000) Epidermal growth factor negatively
regulates chondrogenesis of mesenchymal cells by modulating the
protein kinase C-alpha, Erk-1, and p38 MAPK signaling pathways.
J Biol Chem 275, 12353 – 12359.
26 Pang, L., Sawada, T., Decker, S.J & Saltiel, A.R (1995) Inhibition
of MAP kinase kinase blocks the differentiation of PC-12
cells induced by nerve growth factor J Biol Chem 270,
13585– 13588.
27 Murakami, S., Kan, M., McKeehan, W.L & de Crombrugghe, B.
(2000) Up-regulation of the chondrogenic Sox9 gene by fibroblast
growth factors is mediated by the mitogen-activated protein kinase
pathway Proc Natl Acad Sci USA 97, 1113 – 1118.
28 Yonekura, A., Osaki, M., Hirota, Y., Tsukazaki, T., Miyazaki, Y.,
Matsumoto, T., Ohtsuru, A., Namba, H., Shindo, H & Yamashita,
S (1999) Transforming growth factor-beta stimulates articular
chondrocyte cell growth through p44/42 MAP kinase (ERK)
activation Endocr J 46, 545 – 553.
29 Hirota, Y., Tsukazaki, T., Yonekura, A., Miyazaki, Y., Osaki, M.,
Shindo, H & Yamashita, S (2000) Activation of specific
MEK-ERK cascade is necessary for TGF beta signaling and crosstalk
with PKA and PKC pathways in cultured rat articular chondrocytes.
Osteoarthritis Cartilage 8, 241 – 247.
30 Rao, V.N & Reddy, E.S (1994) elk-1 proteins interact with MAP
kinases Oncogene 9, 1855 – 1860.
31 Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J.A., Lin, S & Han, J.
(1996) Characterization of the structure and function of a new
mitogen- activated protein kinase (p38beta) J Biol Chem 271,
17920– 17926.
32 Davis, R.J (2000) Signal transduction by the JNK group of MAP
kinases Cell 103, 239 – 252.
33 Hill, C.S & Treisman, R (1995) Transcriptional regulation by
extracellular signals: mechanisms and specificity Cell 80,
199 – 211.
34 Moriguchi, T., Kuriyanagi, N., Yamaguchi, K., Gotchi, Y., Irie, K.,
Kano, T., Shirakabe, K., Muro, Y., Shibuya, H., Matsumoto, K.,
et al (1996) A novel kinase cascade madiated by mitogen-activated
protein kinase kinase 6 and MKK3 J Biol Chem 271,
13675– 13679.
35 Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T & Saltiel, A.R.
(1995) PD 098059 is a specific inhibitor of the activation of
mitogen-activated protein kinase kinase in vitro and in vivo J Biol.
Chem 270, 27489– 27494.
36 Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J & Saltiel, A.R.
(1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade Proc Natl Acad Sci USA 92, 7686 – 7689.
37 Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R & Lee, J.C (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 FEBS Lett 364, 229 – 233.
38 Kawamura, H., Otsuka, T., Matsuno, H., Niwa, M., Matsui, N., Kato, K., Uematsu, T & Kozawa, O (1999) Endothelin-1 stimulates heat shock protein 27 induction in osteoblasts: involve-ment of p38 MAP kinase Am J Physiol 277, E1046 – E1054.
39 Tamura, T., Nakanishi, T., Kimura, Y., Hattori, T., Sasaki, K., Norimatsu, H., Takahashi, K & Takigawa, M (1996) Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascular-ization in arthritis Endocrinology 137, 3729 – 3737.
40 Sasaki, K., Hattori, T., Fujisawa, T., Takahashi, K., Inoue, H & Takigawa, M (1998) Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes J Biochem.
123, 431 – 439.
41 Zhen, X., Wei, L., Wu, Q., Zhang, Y & Chen, Q (2000) Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone J Biol Chem 29, 29.
42 Nakamura, K., Shirai, T., Morishita, S., Uchida, S., Saeki-Miura, K.
& Makishima, F (1999) p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/ differentiation factor-5 in ATDC5 cells Exp Cell Res 250,
351 – 363.
43 Liu, C., Liu, X.J., Crowe, P.D., Kelner, G.S., Fan, J., Barry, G., Manu, F., Ling, N., De Souza, E.B & Maki, R.A (1999) Nephro-blastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation Gene 238, 471 – 478.
44 Miwa, M., Kozawa, O., Tokuda, H & Uematsu, T (1999) Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C Endocrinology 140, 5120 – 5125.
45 De´rijard, B., Raingeaud, J., Barrett, T., Wu, I.H., Han, J., Ulevitch, R.J., Davis, R.J (1995) Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms Science 267, 682 – 685.
46 Enslen, H., Raineaud, J & Davis, R.J (1998) Selective activation
of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinase MKK3 and MKK6 J Biol Chem 273,
1741 – 1748.